Clinical Trials

Carcinoma, Renal Cell

NCT01352962 2026-04-14

Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors

GastrointestinalGenitourinaryGynecologicThoracic

18 enrolled

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Pancreatic Neoplasms, Ureteral Neoplasms, Urethral Neoplasms

NCT01902680 2026-04-14

CURIEFOCALE

18 enrolled

Prostatic Neoplasms

NCT05410509 2026-04-14

"Embolization Before Ablation of Renal Cell Carcinoma (EMBARC)"

25 enrolled

Carcinoma, Renal Cell

NCT01982786 2026-04-13

Feasibility Trial Of Image Guided External Beam Radiotherapy With Or Without High Dose Rate Brachytherapy Boost In Men With Intermediate-Risk Prostate Cancer

57 enrolled 16 charts

Prostatic Neoplasms

NCT02225704 2026-04-13

Radium-223 in Combination With Enzalutamide

45 enrolled

Prostatic Neoplasms

NCT02711202 2026-04-13

Sequential Targeting of Cluster of Differentiation 52 (CD52) and Tumor Necrosis Factor (TNF) Allows Early Minimization Therapy in Kidney Transplantation

20 enrolled 11 charts

Kidney Transplantation

NCT02772588 2026-04-13

AASUR in High Risk Prostate Cancer

64 enrolled 7 charts

Prostatic Neoplasms

NCT03213665 2026-04-13

Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial)

CNSGastrointestinalGenitourinaryLymphoidMyeloidSarcoma

20 enrolled 12 charts

Ependymoma, Glioma, Histiocytosis, Langerhans-Cell, Hodgkin Disease, Lymphoma, Non-Hodgkin, Medulloblastoma, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Central Nervous System Neoplasms, Hepatoblastoma, Neuroectodermal Tumors, Primitive, Peripheral, Rhabdoid Tumor

NCT02433197 2026-04-08

EFICATEST

20 enrolled

Motor Activity, Neoplasms, Germ Cell and Embryonal, Testicular Neoplasms

NCT04081779 2026-04-08

Survivorship Care Plans and Telehealth Education for the Improvement of Access to Cancer Survivorship, the IMPACT Study

BreastGastrointestinalGenitourinaryLymphoidThoracic

261 enrolled

Breast Neoplasms, Lung Neoplasms, Lymphoma, Prostatic Neoplasms, Colorectal Neoplasms

NCT06020651 2026-04-08

VICKI

39 enrolled

Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Neoplasms, Vascular Diseases, Atherosclerosis

NCT04037254 2026-04-06

Testing the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Therapy) for Prostate Cancer With a High Chance of Recurring

Phase 1/2 Completed

22 enrolled 13 charts

Prostatic Neoplasms

NCT04533958 2026-04-06

HypProMet

53 enrolled

Anxiety Disorders, Neoplasms, Prostatic Neoplasms

NCT04582656 2026-04-06

VIOLETTE

76 enrolled

Neoplasms, Prostatic Neoplasms

NCT03526250 2026-04-03

Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)

CNSGastrointestinalGenitourinaryLymphoidMyeloidSarcoma

23 enrolled 11 charts

Familial ependymoma, Ependymoma, Glioma, Histiocytosis, Langerhans-Cell, Lymphoma, Non-Hodgkin, Medulloblastoma, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Hepatoblastoma, Neuroectodermal Tumors, Primitive, Peripheral, Rhabdoid Tumor

NCT03660085 2026-04-03

PC-PEP

140 enrolled 8 charts

Psychological Well-Being, Motor Activity, Prostatic Neoplasms

NCT07510685 2026-04-03

IRIS

240 enrolled

Urinary Bladder Neoplasms, Prostatic Hyperplasia, Catheter-Related Infections

NCT02964078 2026-04-02

Interleukin-2 and Pembrolizumab for Metastatic Kidney Cancer

27 enrolled 10 charts

Kidney Diseases, Kidney Neoplasms, Neoplasm Metastasis

NCT03213678 2026-04-02

Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)

CNSGastrointestinalGenitourinaryLymphoidMyeloidSarcoma

18 enrolled 12 charts

Ependymoma, Glioma, Histiocytosis, Langerhans-Cell, Lymphoma, Non-Hodgkin, Medulloblastoma, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Central Nervous System Neoplasms, Hepatoblastoma, Neuroectodermal Tumors, Primitive, Peripheral, Rhabdoid Tumor

NCT02044354 2026-04-01

CABA-DOC

Phase 3 Completed

195 enrolled

Metastatic Castration-resistant Prostate Cancer

NCT02822404 2026-04-01

CysPed

42 enrolled

Kidney Diseases

NCT03798626 2026-04-01

Gevokizumab With Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal Cancers

GastrointestinalGenitourinary

167 enrolled

Carcinoma, Renal Cell, Colorectal Neoplasms

NCT05553327 2026-04-01

Impact of a Multimodal Prehabilitation Program Before Robotic-assisted Radical Prostatectomy.

100 enrolled

Prostatic Neoplasms

NCT07505615 2026-04-01

VG-INFUSE Tria

Phase 1/2 Completed

20 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT02555748 2026-03-31

SUP-R

Phase 4 Completed

47 enrolled

Carcinoma, Renal Cell

NCT03496805 2026-03-31

Effects of Muscadine Grape Extract in Men With Prostate Cancer on Androgen Deprivation Therapy

106 enrolled 10 charts

Prostatic Neoplasms

NCT03674814 2026-03-31

Study of Drug 1 (Enzalutamide) Plus Drug 2 (Relacorilant) for Patients With Prostate Cancer

42 enrolled

Prostatic Neoplasms

NCT05231915 2026-03-31

HOXB13_Mart

465 enrolled

Prostatic Neoplasms

NCT04705038 2026-03-27

Effect of Education on Treatment Decision Making for Patients With Prostate Cancer on Chronic Hormone Treatments

101 enrolled

Prostatic Neoplasms

NCT05226117 2026-03-27

Sacituzumab Govitecan, Preceding Radical Cystectomy, in Treating Patients With Muscle-invasive Bladder Cancer

44 enrolled

Carcinoma, Transitional Cell

NCT06435546 2026-03-27

AdOTAC

200 enrolled

BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

NCT07074405 2026-03-27

AccAI

51 enrolled

Prostatic Neoplasms

NCT03197896 2026-03-25

Educational Intervention in Increasing Knowledge About Prostate Cancer in High-Risk Neighborhoods

239 enrolled 6 charts

Prostate

NCT04461509 2026-03-25

High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical Prostatectomy

62 enrolled 11 charts

Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

NCT07489729 2026-03-24

Hypo Fractionated Versus Conventional IMRT in Unfavorable Intermediate- and High-Risk Prostate Cancer

60 enrolled

Prostatic Neoplasms

NCT02690558 2026-03-20

Phase 2 Study of Pembrolizumab in Combination With Gemcitabine and Cisplatin as Neoadjuvant Therapy

39 enrolled 16 charts

Urinary Bladder Neoplasms

NCT03088124 2026-03-20

PC-ARN

93 enrolled

Low Risk Prostate Cancer

NCT04055311 2026-03-19

Recovery Support for Bladder Cancer Patients and Caregivers

174 enrolled 29 charts

Urinary Bladder Neoplasms, Patient Participation

NCT06136598 2026-03-19

MK-5684-001

14 enrolled

Prostatic Neoplasms

NCT06108479 2026-03-18

Study of DF6215 in Patients With Advanced Solid Tumors

DermatologicGenitourinaryGynecologicHead & NeckThoracic

35 enrolled

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Head and Neck Neoplasms, Melanoma, Neoplasms, Ovarian Neoplasms

NCT07481123 2026-03-18

COMPARISON OF OBTURATOR NERVE BLOCK TECHNIQUES IN TURBT

60 enrolled

Urinary Bladder Neoplasms

NCT03258593 2026-03-17

Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)

15 enrolled 21 charts

Urinary Bladder Neoplasms, Carcinoma in Situ

NCT03274687 2026-03-16

Hypofractionated Radiation Therapy or Conventional Radiation Therapy After Surgery in Treating Patients With Prostate Cancer

Phase 3 Completed

296 enrolled 29 charts

Prostate Adenocarcinoma

NCT06894771 2026-03-16

MK-4700-001

BreastDermatologicGenitourinaryGynecologicHead & NeckThoracic

5 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Melanoma, Neoplasms, Triple Negative Breast Neoplasms

NCT01596816 2026-03-13

CKNO-PRO

76 enrolled